SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-095348
Filing Date
2016-02-03
Accepted
2016-02-03 16:53:39
Documents
2
Period of Report
2016-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2206
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4288
  Complete submission text file 0001209191-16-095348.txt   7797
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 700 PENNSYLVANIA DR EXTON PA 19341
Business Address
MANNING MARTHA E (Reporting) CIK: 0001227894 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 161385475